How Big Food Is Navigating the GLP-1 Era
Summary
The Journal explores how major food manufacturers like Conagra and General Mills are adapting to the rise of GLP-1 weight loss drugs, which alter taste perception and reduce cravings. Host Jessica Mendoza and reporter Amira McKee discuss how companies use test kitchens and AI personas to develop high-protein products that appeal to these consumers while maintaining traditional snacks for the broader market. The episode highlights the industry's shift from targeting cravings to prioritizing nutritional attributes like protein and fiber to retain revenue amidst changing dietary habits.
Topics discussed
Inside Conagra's test kitchen and the GLP-1 shift
Show intro and sponsor ads
Food industry engineering cravings and textures
How GLP-1 drugs alter taste and cravings
Economic impact on households and industry revenue
New consumer needs: protein, fiber, and health
Broader industry challenges: inflation and costs
Sponsor ads and transition to solutions
Packaging badges and recipe development trials
Tasting a high-protein buffalo mac and cheese
Using data and AI personas for product insight
Why GLP-1 trends are lasting vs. past diets
Balancing health trends with traditional snacks
Outro and final sponsor ads
Listen ad-free on Castria